COMMUNIQUÉS West-GlobeNewswire

Abeona Therapeutics Announces CEO Transition
26/11/2018
Dr. Carsten Thiel to Depart Company Immediately; Dr. João Siffert Appointed Interim CEO NEW YORK and CLEVELAND, Nov. 26, 2018 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a leading clinical-stage [...]
Abattis Bioceuticals Celebrates Release of Comfort Through Vergence Naturals
26/11/2018
VANCOUVER, British Columbia, Nov. 26, 2018 (GLOBE NEWSWIRE) -- Abattis Bioceuticals Corp (the “ Company ” or “ Abattis ”) (CSE:ATT) (OTC:ATTBF) is pleased to announce the release of its first proprietary product, [...]
Amarin Announces Proposed Public Offering of American Depositary Shares
26/11/2018
BEDMINSTER, N.J. and DUBLIN, Ireland, Nov. 26, 2018 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN) today announced a registered underwritten public offering of its American Depositary Shares (“ADSs”). All of [...]
Transparency notification
26/11/2018
Mechelen, Belgium; 26 November 2018; 22.01 CET; regulated information - Galapagos NV (Euronext & NASDAQ: GLPG) received a transparency notification from Van Herk Investments B.V . Pursuant to Belgian transparency [...]
G1 Therapeutics Announces Positive Myelopreservation Data from Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of Trilaciclib in Combination with Chemotherapy/Tecentriq® in First-Line Small Cell Lung Cancer
26/11/2018
Second randomized, double-blind, placebo-controlled Phase 2 trial confirms multi-lineage myelopreservation benefits of trilaciclib in first-line small cell lung cancer (1L SCLC) Statistically significant improvements in [...]
CareDx Strengthens Executive Leadership Team with the Appointment of Reginald Seeto, MB.BS, as President and Chief Business Officer
26/11/2018
BRISBANE, Calif., Nov. 26, 2018 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high- [...]
Tyme Technologies, Inc. to Present at the Piper Jaffray Healthcare Conference on November 28th
26/11/2018
NEW YORK, Nov. 26, 2018 (GLOBE NEWSWIRE) -- Tyme Technologies, Inc. (NASDAQ:TYME), a clinical stage biotechnology company developing cancer therapeutics to address multiple tumor types, today announced that it will be [...]
Cytokinetics Announces Five Presentations at the International Symposium on ALS/MND
26/11/2018
SOUTH SAN FRANCISCO, Calif., Nov. 26, 2018 (GLOBE NEWSWIRE) -- Cytokinetics, Inc. (Nasdaq: CYTK) today announced five poster presentations at the 29 th International Symposium on ALS/MND in Glasgow, Scotland, UK. The [...]
VitalHub Continues to Report Positive Adjusted EBITDA Results and Increased Revenues
26/11/2018
TORONTO, Nov. 26, 2018 (GLOBE NEWSWIRE) -- VitalHub Corp. (the “Company” or “VitalHub”) (TSXV: VHI) announced today it has filed its Interim Condensed Consolidated Financial Statements and Management's Discussion and [...]
Xbrane Biopharma presents nomination committee
26/11/2018
Press release 2018-11-26 In accordance with the principles of the nomination committee of Xbrane Biopharma AB (" Company " or " Xbrane "), adopted at the Annual General Meeting on 24 May 2018, the Nomination Committee [...]
Hair Today, Gone Tomorrow: Dermatologists Debunk Common Misconceptions About Laser Hair Removal; American Academy of Dermatology
26/11/2018
AAD warns consumers that laser hair removal can be dangerous in inexperienced hands ROSEMONT, Ill., Nov. 26, 2018 (GLOBE NEWSWIRE) -- When performed by a doctor, laser hair removal is a safe, effective and permanent [...]
iCAD Unveils ProFound AI™ for Digital Breast Tomosynthesis at RSNA 2018
26/11/2018
Clinical results presented demonstrate outstanding outcomes with world-class artificial intelligence NASHUA, N.H. and CHICAGO, Nov. 26, 2018 (GLOBE NEWSWIRE) -- (Booth #3911 and #8161) – iCAD, Inc. (NASDAQ: ICAD), a [...]
Sanofi: Disclosure of trading in own shares
26/11/2018
Attachment Reporting EN.pdf
Sanofi : Déclaration des transactions sur actions propres
26/11/2018
Pièce jointe Reporting FR.pdf
OSE Immunotherapeutics Receives Belgian Authorization for a Phase 1 Clinical Trial to Evaluate Anti-IL-7 Receptor Antagonist OSE-127
26/11/2018
NANTES, France, Nov. 26, 2018 (GLOBE NEWSWIRE) -- OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnémo: OSE) today announced authorization by Federal Agency for Medicines and Health Products (FAMH) and Belgian Ethics [...]
Opthea Confirms Final Patient Enrolment in Phase 2b Wet AMD Clinical Trial
26/11/2018
MELBOURNE, Australia, Nov. 26, 2018 (GLOBE NEWSWIRE) -- Opthea Limited (ASX:OPT), a clinical stage biopharmaceutical company developing novel biologic therapies to treat eye diseases, is pleased to report that the last [...]
Vital® Celebrates 30 Years of Leadership at RSNA 2018
26/11/2018
A global leader in healthcare imaging, Vital is excited to share its latest innovations in enterprise imaging MINNETONKA, Minn., Nov. 26, 2018 (GLOBE NEWSWIRE) -- Built on 30 years of innovation and leadership in [...]
Ossur Hf : Transactions in relation to share buyback program
26/11/2018
Announcement no. 68/2018 26 November 2018 Transactions in relation to share buyback program On 9 October 2018, Össur hf. initiated a share buy-back program, see Company announcement no. 59/2018. The purpose of the share [...]
Zealand Pharma announces change in Executive Management
26/11/2018
Company announcement – No. 29/2018 Zealand Pharma announces change in Executive Management Copenhagen, Denmark, November 26, 2018 – Zealand Pharma A/S announces that Britt Meelby Jensen has today delivered her notice to [...]

Pages